These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antibody responses to Haemophilus influenzae type b and Streptococcus pneumoniae vaccines in children with human immunodeficiency virus infection. Gibb D; Spoülou V; Giacomelli A; Griffiths H; Masters J; Misbah S; Nokes L; Pagliaro A; Giaquinto C; Kroll S Pediatr Infect Dis J; 1995 Feb; 14(2):129-35. PubMed ID: 7746695 [TBL] [Abstract][Full Text] [Related]
23. Human T lymphotropic virus type II infection and humoral responses to pneumococcal polysaccharide and tetanus toxoid vaccines. Jarvis GA; Janoff EN; Cheng H; Devita D; Fasching C; McCulloch CE; Murphy EL J Infect Dis; 2005 Apr; 191(8):1239-44. PubMed ID: 15776369 [TBL] [Abstract][Full Text] [Related]
24. Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant. Wuorimaa T; Dagan R; Väkeväinen M; Bailleux F; Haikala R; Yaich M; Eskola J; Käyhty H J Infect Dis; 2001 Nov; 184(9):1211-5. PubMed ID: 11598848 [TBL] [Abstract][Full Text] [Related]
25. Immunization of female mice with glycoconjugates protects their offspring against encapsulated bacteria. Richter MY; Jakobsen H; Birgisdottir A; Haeuw JF; Power UF; Del Giudice G; Bartoloni A; Jonsdottir I Infect Immun; 2004 Jan; 72(1):187-95. PubMed ID: 14688096 [TBL] [Abstract][Full Text] [Related]
26. Prolonged and preferential production of polymeric immunoglobulin A in response to Streptococcus pneumoniae capsular polysaccharides. Johnson S; Opstad NL; Douglas JM; Janoff EN Infect Immun; 1996 Oct; 64(10):4339-44. PubMed ID: 8926108 [TBL] [Abstract][Full Text] [Related]
27. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies. Lue C; Tarkowski A; Mestecky J J Immunol; 1988 Jun; 140(11):3793-800. PubMed ID: 3372993 [TBL] [Abstract][Full Text] [Related]
28. Antibodies to pneumococcal capsular polysaccharides in children with human immunodeficiency virus infection given polyvalent pneumococcal vaccine. Arpadi SM; Back S; O'Brien J; Janoff EN J Pediatr; 1994 Jul; 125(1):77-9. PubMed ID: 8021792 [TBL] [Abstract][Full Text] [Related]
29. Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid. Ahman H; Käyhty H; Vuorela A; Leroy O; Eskola J Vaccine; 1999 Jun; 17(20-21):2726-32. PubMed ID: 10418924 [TBL] [Abstract][Full Text] [Related]
30. Cattle immune responses to tetanus toxoid elicited by recombinant S. typhimurium vaccines or tetanus toxoid in alum or Freund's adjuvant. Villarreal-Ramos B; Manser JM; Collins RA; Dougan G; Howard CJ Vaccine; 2000 Feb; 18(15):1515-21. PubMed ID: 10618549 [TBL] [Abstract][Full Text] [Related]
31. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines. Parkkali T; Käyhty H; Anttila M; Ruutu T; Wuorimaa T; Soininen A; Volin L; Ruutu P Bone Marrow Transplant; 1999 Sep; 24(6):671-8. PubMed ID: 10490735 [TBL] [Abstract][Full Text] [Related]
32. Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adults. Feikin DR; Elie CM; Goetz MB; Lennox JL; Carlone GM; Romero-Steiner S; Holder PF; O'Brien WA; Whitney CG; Butler JC; Breiman RF Clin Diagn Lab Immunol; 2004 Jan; 11(1):137-41. PubMed ID: 14715560 [TBL] [Abstract][Full Text] [Related]
33. Impaired antibody response to pneumococcal capsular polysaccharides and phosphorylcholine in adult patients with a history of bacteremic pneumococcal infection. Ekdahl K; Braconier JH; Svanborg C Clin Infect Dis; 1997 Sep; 25(3):654-60. PubMed ID: 9314455 [TBL] [Abstract][Full Text] [Related]
34. Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. Rodriguez-Barradas MC; Musher DM; Lahart C; Lacke C; Groover J; Watson D; Baughn R; Cate T; Crofoot G J Infect Dis; 1992 Mar; 165(3):553-6. PubMed ID: 1347058 [TBL] [Abstract][Full Text] [Related]
35. Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections. Hidalgo H; Moore C; Leiva LE; Sorensen RU Ann Allergy Asthma Immunol; 1996 Apr; 76(4):341-6. PubMed ID: 8612116 [TBL] [Abstract][Full Text] [Related]
36. Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid. Korkeila M; Lehtonen H; Ahman H; Leroy O; Eskola J; Käyhty H Vaccine; 2000 Jan; 18(13):1218-26. PubMed ID: 10649623 [TBL] [Abstract][Full Text] [Related]
37. T-cell-independent and T-cell-dependent antibody responses in patients with chronic renal failure. Beaman M; Michael J; MacLennan IC; Adu D Nephrol Dial Transplant; 1989; 4(3):216-21. PubMed ID: 2498780 [TBL] [Abstract][Full Text] [Related]
38. Immunoglobulin G (IgG) subclass distribution and IgG1 avidity of antibodies in human immunodeficiency virus-infected individuals after revaccination with tetanus toxoid. Kroon FP; van Tol MJ; Jol-van der Zijde CM; van Furth R; van Dissel JT Clin Diagn Lab Immunol; 1999 May; 6(3):352-5. PubMed ID: 10225835 [TBL] [Abstract][Full Text] [Related]